AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Webcast Corporate Update Conference Call SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. plans to webcast a Corporate Update Conference Call on Tuesday, November 25, 2003 at 10:00 a.m. Eastern/7:00 a.m. Pacific. The call will be led by Ginger L. Graham, Amylin's President and Chief Executive Officer. The call will be webcast live through Amylin's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to http://www.amylin.com/ approximately fifteen minutes prior to the call to register, download and install any necessary audio software. A recording will be available by phone for 24 hours beginning approximately one hour after the close of the call and can be accessed at 888-286-8010 (domestic) or 617-801-6888 (international), passcode 38633452. Amylin Pharmaceuticals is engaged in the discovery, development and commercialization of potential drug candidates for the treatment of diabetes and other metabolic diseases. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright